PDMC Implementation Trial in Kenya

Recruiting now · Phase 4

Conditions studied: Severe Malaria, Severe Anemia

In brief

The goal of this implementation trial is to evaluate at least two alternative delivery strategies and adherence support for malaria chemoprevention with dihydroartemisinin-piperaquine in the post-discharge management of children hospitalised with severe anaemia or severe malaria to optimise adherence in Kenya. The actual interventions to be evaluated have been co-designed with national stakeholders during an initial formative research stage.

Key facts

Study ID
NCT06624631
Run by
Liverpool School of Tropical Medicine
People needed
600
Starts
2025-09-05
Expected to finish
2026-09-30
Last updated by the study team
2025-11-21

Who can join

Age: any, up to 9. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.